{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T07:13:12Z","timestamp":1794899592742,"version":"4.9.1"},"reference-count":11,"publisher":"BMJ","issue":"3","funder":[{"name":"Northern Alberta Academic Family Medicine Fund"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Qual"],"accepted":{"date-parts":[[2019,8,6]]},"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:p>Benzodiazepines are recognised as being potentially inappropriate medications for seniors due to their considerable side-effect profile, yet they are commonly prescribed and infrequently discontinued (deprescribed). The study\u2019s primary objective was the deprescription or the dose reduction of benzodiazepines among newly hospitalised seniors using a patient education intervention. A 3-month duration quality improvement study based on the plan\u2013do\u2013study\u2013act model was conducted across two units (3C and 4D) in the Glenrose Rehabilitation Hospital to improve benzodiazepine deprescribing among newly admitted seniors (65 years or older) who were using benzodiazepines. The primary outcome measure was the number of eligible patients who had benzodiazepine deprescribing initiated. A patient education intervention comprising a structured medication review, written patient education (the Eliminating Medications Through Patient Ownership of End Results (EMPOWER) brochure) and at least one brief supportive counselling session by the clinical pharmacist or physician was applied to all eligible patients. All 12 eligible patients consented to benzodiazepine deprescribing; however, only 11 of them (92%) initiated benzodiazepine deprescribing. Six of the 11 patients (55%) had their benzodiazepines discontinued, with the 5 remaining patients (45%) achieving greater than 50% dosage reduction. Seven patients (64%) experienced side effects during the deprescribing process, with over half (57%, n=4) of these seven patients experiencing worsening anxiety symptoms. Five of the 11 patients (45%) required benzodiazepine substitute medications. The use of a structured patient education intervention involving the use of a structured medication review, written patient education material and one-on-one patient counselling can promote benzodiazepine deprescribing. Although worsening anxiety was frequently observed, this was easily managed by the substitution of a more appropriate and clinically indicated medication, which was well tolerated and acceptable by all of our participants. Targeted screening for the presence of anxiety would help to guide the deprescribing process and the need for medication substitution.<\/jats:p>","DOI":"10.1136\/bmjoq-2018-000539","type":"journal-article","created":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T05:55:13Z","timestamp":1566366913000},"page":"e000539","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":23,"title":["Deprescribing benzodiazepines among hospitalised older adults: quality improvement initiative"],"prefix":"10.1136","volume":"8","author":[{"given":"Frances","family":"Carr","sequence":"first","affiliation":[{"name":"Division of Geriatrics, Department of Medicine, University of Alberta Hospital, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Tian","sequence":"additional","affiliation":[{"name":"Division of Care of the Elderly, Department of Family Medicine, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Chow","sequence":"additional","affiliation":[{"name":"Glenrose Rehabilitation Hospital, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Guzak","sequence":"additional","affiliation":[{"name":"Glenrose Rehabilitation Hospital, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Triscott","sequence":"additional","affiliation":[{"name":"Division of Care of the Elderly, Department of Family Medicine, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Mathura","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie","family":"Dobbs","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,8,20]]},"reference":[{"key":"2025083114225693000_8.3.e000539.1","unstructured":"AHS . AHS Tableau workbook: Alberta community pharmacy prescribed medication-per population (2015\/2016); 2017."},{"key":"2025083114225693000_8.3.e000539.2","unstructured":"AHS . AHS Tableau workbook: Alberta population counts by user selected resident geography (2015\/2016); 2017."},{"key":"2025083114225693000_8.3.e000539.3","first-page":"107","article-title":"Adverse effects of benzodiazepine use in elderly people: a meta-analysis","volume":"7","author":"Sithamparanathan","year":"2012","journal-title":"Asian J Gerontol Geriatr"},{"key":"2025083114225693000_8.3.e000539.4","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.13702."},{"key":"2025083114225693000_8.3.e000539.5","doi-asserted-by":"publisher","DOI":"10.1002\/pds.865"},{"key":"2025083114225693000_8.3.e000539.6","unstructured":"CoPaSo A , Toolkit C . Benzodiazepines: use and taper. Canada College of Physicians and Surgeons of Alberta; 2016. http:\/\/www.cpsa.ca\/your-practice\/prescribing-resources-tools\/"},{"key":"2025083114225693000_8.3.e000539.7","unstructured":"Society CG . Geriatrics: five things physicians and patients should question Toronto, Canada Canadian Medical association, 2014. Available: http:\/\/www.choosingwiselycanada.org\/recommendations\/geriatrics\/"},{"key":"2025083114225693000_8.3.e000539.8","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12732"},{"key":"2025083114225693000_8.3.e000539.9","unstructured":"Farrell B , Tannenbaum C . deorescribing.org: Bruyere, 2017. Available: http:\/\/deprescribing.org\/about\/"},{"key":"2025083114225693000_8.3.e000539.10","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/jamainternmed.2014.949","article-title":"Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the empower cluster randomized trial","volume":"174","author":"Tannenbaum","year":"2014","journal-title":"JAMA Intern Med"},{"key":"2025083114225693000_8.3.e000539.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2013.02.016"}],"container-title":["BMJ Open Quality"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjoq-2018-000539","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T21:23:04Z","timestamp":1756675384000},"score":1,"resource":{"primary":{"URL":"https:\/\/qir.bmj.com\/lookup\/doi\/10.1136\/bmjoq-2018-000539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":11,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,8,20]]},"published-print":{"date-parts":[[2019,8]]}},"alternative-id":["10.1136\/bmjoq-2018-000539"],"URL":"https:\/\/doi.org\/10.1136\/bmjoq-2018-000539","relation":{},"ISSN":["2399-6641"],"issn-type":[{"value":"2399-6641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8]]}}}